B
Bo Heng Zhang
Researcher at Fudan University
Publications - 6
Citations - 462
Bo Heng Zhang is an academic researcher from Fudan University. The author has contributed to research in topics: Hepatocellular carcinoma & Cancer. The author has an hindex of 4, co-authored 6 publications receiving 309 citations. Previous affiliations of Bo Heng Zhang include Chinese Ministry of Education.
Papers
More filters
Journal ArticleDOI
Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition).
Jian Zhou,Hui-Chuan Sun,Zheng Wang,Wen Ming Cong,Jian-Hua Wang,Meng Su Zeng,Jia Mei Yang,Ping Bie,Lianxin Liu,Tian Fu Wen,Guo Hong Han,Mao Qiang Wang,Rui Bao Liu,Li Gong Lu,Zheng Gang Ren,Minshan Chen,Zhao Chong Zeng,Ping Liang,Changhong Liang,Min Chen,Fu Hua Yan,Wen Ping Wang,Yuan Ji,Wen Wu Cheng,Chao Liu Dai,Wei-Dong Jia,Ya Ming Li,Ye Xiong Li,Jun Liang,Tian Shu Liu,Guo Yue Lv,Yi Lei Mao,Wei Xin Ren,Hong Cheng Shi,Wen Tao Wang,Xiaoying Wang,Bao Cai Xing,Jian Ming Xu,Jian Yong Yang,Ye Fa Yang,Sheng Long Ye,Zheng Yu Yin,Bo Heng Zhang,Shui Jun Zhang,Wei Ping Zhou,Ji Ye Zhu,Rong Liu,Ying Hong Shi,Yong Sheng Xiao,Zhi Dai,Gao Jun Teng,Jian Qiang Cai,Wei Lin Wang,Jia Hong Dong,Qiang Li,Feng Shen,Shu Kui Qin,Jia Fan +57 more
TL;DR: A guideline on the surveillance, diagnosis, staging, and treatment of HCC occurring in China is presented, and recommendations regarding patients with HCC in China are made to ensure optimum patient outcomes.
Journal ArticleDOI
Prognostic Nomogram Based on Histological Characteristics of Fibrotic Tumor Stroma in Patients Who Underwent Curative Resection for Intrahepatic Cholangiocarcinoma
Chu Yu Jing,Yi Peng Fu,Jin Long Huang,Mei Xia Zhang,Yong Yi,Wei Gan,Xin Xu,Hu Jia Shen,Jia Jia Lin,Su Su Zheng,Juan Zhang,Jian Zhou,Jia Fan,Zheng Gang Ren,Shuang Jian Qiu,Bo Heng Zhang +15 more
TL;DR: In intrahepatic cholangiocarcinoma (ICC), the histological maturity of FTS is a robust prognostic indicator for patients who underwent curative resection and the prognostic nomogram constructed on the maturity ofFTS possessed higher predictive power relative to the conventional tumor-node-metastasis staging systems.
Journal ArticleDOI
Prognostic value of peritumoral heat-shock factor-1 in patients receiving resection of hepatocellular carcinoma
Zhang Jb,Kun Guo,Kun Guo,Hui-Chuan Sun,Hui-Chuan Sun,Xiao-Dong Zhu,Xiao-Dong Zhu,Bo-Heng Zhang,Bo-Heng Zhang,Zhifei Lin,Zhifei Lin,Bo Heng Zhang,Bo Heng Zhang,Yinkun Liu,Yinkun Liu,Zhenggang Ren,Zhenggang Ren,Jianping Fan,Jianping Fan +18 more
TL;DR: High peritumoral HSF1 expression can serve as a sensitive ‘readout’ for high-risk HCC ER, and could be a potential metabolic intervention target following curative resection.
Journal Article
Hepatocellular Carcinoma: The Role of Screening.
TL;DR: Alpha-fetoprotein serosurvey plus ultrasonography has been employed as the principal screening approach for early detection of subclinical HCC and has proven to be an important approach to improve overall prognosis, and has also led to changing concepts in clinical research into HCC.
Journal Article
Prospective randomized trial of RFA and chemotherapy for unresectable small hepatocellular carcinoma
Yu hong Gan,Sheng Long Yie,Zheng Gang Ren,Jing lin Xia,Bo Heng Zhang,Yan Hong Wang,Ning ling Ge,Y. Chen,Bi Wei Yang +8 more
TL;DR: RFA combined with systemic chemotherapy is safe, and it can reduce the local recurrence of unresectable small hepatocellular carcinoma, as well as other cancer types, through a prospective randomized trial.